The Aflac Cancer and Blood Disorders Center of Emory University is one of the leading pediatric cancer, hematology, and blood and marrow transplant (BMT) programs in the US. As such it provides advanced diagnostic and clinical care, as well as innovative treatment and research options to children, adolescents and young adults.
Dr. Richard Moriggl gave a presentation at the Aflac Leukemia/Lymphoma group meeting entitled:
"Gene dosage of STAT5 alters lymphocyte development and cancer progression with a key role for the CD8 T cell lineage"